Medical Imaging in Breast Cancer Abstract Medical imaging is widely used in the screening and diagnosing of breast cancer, with recommended methods of screening changing over time. Common medical imaging methods today include mammography, breast magnetic resonance imaging, computed tomography, and elastography. While different technologies vary in accuracy, cost, and approaches for analyzing breast tissue, they are usually non-invasive, safe, use minimal radiation, and can differentiate between malignant and benign tumours. The future of breast cancer screening is closely related to artificial intelligence (AI). Convolutional neural networks (CNNs) use Al algorithms to decipher imaging and can lessen the workload on radiologists. It is predicted that using two-dimensional imaging paired with tomosynthesis will become the new norm of routine scans, as they provide more accuracy. Although these medical imaging technologies are beneficial, there are some ethical and social issues regarding medical imaging including the imbalanced economic status of patients, current problems with the application of Al, and data security. Introduction Breast cancer is the most common cancer among women. It is estimated that 1 in 8 women are at risk for developing breast cancer (Bevers et al., 2009). In recent years, advancements in medical imaging techniques to diagnose breast cancer have resulted in earlier diagnoses of breast cancer, leading to a longer life expectancy among breast cancer patients. This can also be beneficial to radiologists and doctors, who can diagnose patients
more efficiently and provide better care. High-quality medical imaging establishes a better research base for scientists and pathologists and creates potential for a cure. By reviewing the different approaches of breast cancer screening, the current state of screening can be better understood, along with the social and ethical implications. This can help researchers better understand what can be improved for the future. Various papers relating to medical imaging in breast cancer are examined to address the topic, including peer-reviewed, authoritative sources. A thorough investigation of medical imaging in breast cancer is provided in this paper, through the combination of separate research of different areas regarding this topic. Members discussed various imaging approaches, current techniques used for screening and diagnosing breast cancer, the future of medical imaging, and the ethical and social issues that come with it. Current State of Screening/Diagnosis Screening is recommended in order to detect symptoms of breast cancer in its early stages, as breast cancer is easier to treat at that time. The recommendations for screening and diagnosis have regularly varied with age, although the types of screening done for certain age groups have changed over time. Historically it was recommended that women start a breast self-exam (BSE) in their high school years, performing the exam monthly (American Cancer Society, 2021). The BSE includes inspecting the breasts to see if there are any noticeable changes. BSEs were no longer recommended by most clinics after 2015, as there was no evidence to suggest that these exams are effective for detecting breast cancer. There is still value in a patient being familiar with their breasts so that they develop